Stamford, CT -- (SBWIRE) -- 12/27/2013 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Inovio Pharmaceuticals Inc(NYSEMKT:INO), Federal National Mortgage Assctn Fnni Me(OTCBB:FNMA), ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA)
Inovio Pharmaceuticals Inc(NYSEMKT:INO) opened the session at $2.51, remained amid the day range of $2.50 - $2.97, and closed the session at $2.97. The stock showed a positive performance of +20.24% in previous trading session. The stock gained a volume of 22.51 million shares and the average volume of the stock remained 3.44 million shares. Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases.
Why Should Investors Buy INO After The Recent Gain? Just Go Here and Find Out
Federal National Mortgage Assctn Fnni Me(OTCBB:FNMA) traded with volume of 4.31 million shares in the prior session and the average volume of the stock remained 28.81 million shares. The 52 week range of the stock remained $0.25 - $5.44. The stock showed a negative movement of -0.96% and closed its session at $3.09. The market capitalization of the stock remained 3.58 billion. Federal National Mortgage Association (Fannie Mae) provides liquidity and stability support services in the secondary mortgage market in the United States.
Why Should Investors Buy FNMA After the Recent Fall? Just Go Here and Find Out
ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC) exchanged 6.62 million shares and the average volume remained 3.76 million shares. The stock escalated +7.50% and closed the session at $1.04. The beta of the stock remained 2.71 and the EPS of the stock remained -0.16. The shares outstanding of the stock remained 57.10 million. mmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, engages in developing and commercializing immune-based therapies for the treatment of brain, ovarian, and other solid tumors.
For How Long IMUC will fight for Profitability? Read This Trend Analysis report
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) gained volume of 7.29 million shares, while the average volume remained 4.62 million shares. The stock advanced +6.03% and finished the session Thursday at $5.98. The EPS of the stock remained -0.08. The one month of the stock was -6.56% and three month trend remained positive 1.18%. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
For How Long ARNA’s Gloss will Attract Investors ? Find out via this report
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)